Non-small-cell lung cancer treatment

Revista Portuguesa de Pneumologia

Volumn 8, Issue 3, 2002, Pages 237-259

  Sotto Mayor, Renato ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Lung cancer; Therapeutic

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMIFOSTINE; ANTINEOPLASTIC AGENT; BETA CAROTENE; BETA INTERFERON; CARBOPLATIN; CISPLATIN; CYANOCOBALAMIN; DNA TOPOISOMERASE INHIBITOR; DOCETAXEL; ETRETINATE; FLAVOPIRIDOL; FLUOROURACIL; FOLIC ACID; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; MITOMYCIN; NAVELBINE; NEW DRUG; OXALIPLATIN; PACLITAXEL; RETINOIC ACID; RETINOID; TAXANE DERIVATIVE; TIRAPAZAMINE; TOPOTECAN; UFT; UNINDEXED DRUG;

ADOPTIVE IMMUNOTHERAPY; AGED; BONE MARROW SUPPRESSION; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; GENE THERAPY; HUMAN; LUNG NON SMALL CELL CANCER; MULTIMODALITY CANCER THERAPY; NAUSEA; NEPHROTOXICITY; NEUROPATHY; REVIEW; VOMITING;

EID: 0036330983     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30767-4     Document Type: Review

References (149)

1. Induction Therapy for Locally Advanced Non-Small-Cell Lung Cancer
2. Long-Term Survival after Concurrent Cisplatin/Etoposide (PE) plus Chest Radiotherapy (RT) followed by Surgery in Bulky, Stages IIIA (N2) and IIIB Non-Small-Cell Lung Cancer (NSCLC): 6-Year Outcomes from Southwear 8805
3. Clinical Practice Guidelines for the Treatment of Unresectable Non-Small-Cell Lung Cancer
4. Pretreatment Evaluation of Non-Small-Cell Lung Cancer
5. Clinical Practice Guidelines for the Treatment of Unresectable Non-Small-Cell Lung Cancer
6. Induction Chemotherapy followed by Concurrent Standard Radiotherapy and Daily Low-Dose Cisplatin in Locally Advanced Non-Small-Cell Lung Cancer
7. Histopathologic Prognostic Factors in Resected Adenocarcinomas. Is Nuclear DNA Content Prognostic?
8. Surgery for Second Lung Cancers
9. Patterns of Recurrence and Outcome for Patients with Clinical Stage II Non-Small-Cell Lung Cancer
10. New Gene and Cell-Based Therapies for Lung Cancer
11. Combined Modality Therapy for Unresectable Stage III Non-Small-Cell Lung Cancer. New Chemotherapy Combinations
12. Combined-Modality Treatment of Locally Advanced Non-Small-Cell Lung Cancer. Incorporation of Novel Chemotherapeutics Agents
13. Treatment of Non-Small-Cell Lung Cancer in the Elderly Patient
14. Treatment of Stage IV Non-Small-Cell Lung Cancer
15. Docetaxel como Quimioterapia de Segunda Linha no Carcinoma Pulmonar de Não Pequenas Células
16. Surgical Treatment of Lung Cancer with Adrenal Metastasis
17. New Aspects in Staging of Lung Cancer: Prospective Validation of the International Union Against Cancer TNM Classification
18. New Combinations in the Treatment of Lung Cancer. A Time for Optimism
19. Adjuvant and Neoadjuvant Chemotherapy for Non-Small-Cell Lung Cancer. A Time for Reassessment?
20. New Therapeutic Strategies for Lung Cancer. Biology and Molecular Biology Come of Age
21. Practice Guidelines for Non-Small-Cell Lung Cancer
22. Should all Stage IV Non-Small Cell-Lung Cancer Be Treated Palliatively?
23. Multidisciplinary Cancer Clinics: Their Time has Come
24. Detection of Occult Bone Marrow Micrometastases in Patients with Operable Lung Carcinoma
25. Molecular Staging for Operable Non-Small-Cell Lung Cancer
26. Mitomycin, Ifosfamide and Cisplatin in Unresectable Non-Small-Cell Lung Cancer: Effects on Survival and Quality of Life
27. New Therapeutic Strategies Involving Radiation Therapy for Patients with Non-Small-Cell Lung Cancer
28. Progress in Chemotherapy in Advanced Non-Small-Cell Lung Cancer
29. Surgical Therapy of Early Non-Small-Cell Lung Cancer
30. Surgery for Stage II Non-Small-Cell Lung Cancer
31. Surgical Treatment of Stage IIIA (N2) Non-Small-Cell Lung Cancer
32. T3 Non-Small-Cell Lung Cancer (Stage IIB-IIIA)
33. Induction Therapy and Surgery for I-IIIA, B Non-Small-Cell Lung Cancer
34. A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation Versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
35. Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven Year Follow-up of CALGB 8433
36. Medically Inoperable Lung Carcinoma: The Role of Radiation Therapy
37. Bronchoalveolar Carcinoma. Histopathologic Study of Evolution in a Series of 105 Surgically Treated Patients
38. Effectiveness of Chemotherapy for Advanced Lung Cancer in the Elderly: Instrumental Variable and Propensity Analysis
39. Photodynamic Therapy for Lung Cancer
40. Four Models of the Physician-Patient Relationship
41. Chemotherapy benefit and cost-effectiveness of treatment for advanced lung cancer
42. Is the Evidence in Favour of Neoadjuvant Chemotherapy in Stage IIIA (N2) Non-Small-Cell Lung Cancer Solid Enough?
43. Quality of Life During Chemotherapy in Non-Small-Cell Lung Cancer Patients
44. Second-Line Chemotherapy for Non-Small-Cell Lung Cancer
45. Preoperative Chemotherapy in Stage III Non-Small-Cell Lung Cancer: Long-Term Outcome
46. Combined Chemoradiation Treatment in Stage III Non-Small-Cell Lung Cancer
47. Radioterapia Radical no Cancro do Pulmão Medicamente Inoperável
48. Sequential Chemotherapy and Radiotherapy in Non-Small-Cell Lung Cancer
49. Surgical Therapy of Stage I and Non-T3No Stage II Non-Small-Cell Lung Cancer
50. Prognostic Significance of K-ras Codon 12 Mutations in Patients Resected Stage I and II Non-Small-Cell Lung Cancer
51. Multidisciplinary Approach to Potentially Curable Non-Small-Cell Carcinoma of the Lung
52. The ELVIS Trial: A Phase III Study of Single-Agent Vinorelbine as First-Line Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer
53. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small-cell lung cancer
54. Chemoradiotherapy for Stage IIIA,B Non-Small-Cell Lung Cancer
55. Early Lung Cancer Action Project: Overall Design and Findings from Baseline Screening
56. Prognostic Markers of Metastasis and Angiogenesis in Early-Stage Non-Small-Cell Lung Cancer
57. Treatment of Stage II Lung Cancer (T1N1 and T2N1)
58. Second-Line Chemotherapy in Relapsing or Refractory Non-Small-Cell Lung Cancer: A Review
59. Counting the Costs of Chemotherapy in a National Cancer Institute of Canada Randomized Trial in Non-Small-Cell Lung Cancer
60. New Surgical Options for Elderly Lung Cancer Patients
61. Screening for Lung Cancer in High-Risk Groups: Current Status of Low-Dose Spiral CT Scanning and Sputum Markers
62. Locally Advanced Unresectable Non-Small-Cell Lung Cancer. New Treatment Strategies
63. Combined Modality Treatment for Locally Advanced, Unresectable Non-Small-Cell Lung Cancer
64. E1594 - A Randomized Phase III Trial in Metastatic Non-Small-Cell Lung Cancer (NSCLC) - Outcome of PS 2 Patients (pts): An Eastern Cooperative Group Trial (ECOG)
65. Radiotherapy for Stage I, II Non-Small-Cell Lung Cancer
66. Surgery for Stage I Non-Small-Cell Lung Cancer
67. Lung Cancer Chemoprevention and Management of Carcinoma in Situ
68. Peripheral Lung Cancer: Screening and Detection with Low-Dose Spiral CT versus Radiography
69. Lung Cancer Chemoprevention and Management of Carcinoma in Situ
70. Future Directions for New Cytotoxic Agents in the Treatment of Advanced-Stage Non-Small-Cell Lung Cancer
71. Is it Time to Reevaluate our Approach to the Treatment of Brain Metastases in Patients with Non-Small-Cell Lung Cancer?
72. Combined Chemotherapy and Radiation Therapy in Surgically Unresectable Regionally Advanced Non-Small-Cell Lung Cancer
73. High-Dose-Rate After loading Endobronchial Brachytherapy
74. Treatment of Non-Small-Cell Lung Cancer: Surgery
75. Integrating New Agents and Approaches Into Chemotherapy Regimens for Non-Small-Cell Lung Cancer
76. Disseminated Tumor Cells in Lymph Nodes as a Determinant for Survival in Surgically Resected Non-Small-Cell Lung Cancer
77. Localization of Brochial Intraepitelial Neoplastic Lesions by Fluorescence Bronchoscopy
78. The Role of Thoracoscopy in Lung Cancer Management
79. Hypoxic Cell Radiosensitizers: Past, Present and Future
80. Single-Agent Docetaxel (Taxotere®) in the Treatment of Advanced Non-Small-Cell Lung Cancer: Clinical Concepts and Commentary
81. Discussing Adjuvant Cancer Therapy
82. Induction Platinum-Based Chemotherapy followed by Radical Hyperfractionated Radiotherapy with Concurrent Chemotherapy in the Treatment of Locally Advanced Non-Small-Cell Carcinoma of the Lung
83. Extended Resections for Lung Cancer
84. Actualização do Sistema Internacional de Estadiamento do Cancro do Pulmão
85. Incidence of Local Recurrence and Second Primary Tumors in Resected Stage I Lung Cancer
86. The role of multimodality therapy in locoregional non-small-cell lung cancer
87. Is Lobectomy by Video-assisted Thoracic Surgery an Adequate Cancer Operation?
88. Redefining the Target: Chemotherapeutics as Antiangiogenics
89. Radiotherapy for Adrenal Gland Metastasis from Lung Cancer: Report of Three Cases
90. Utility of Low-Dose Helical CT as a Second Step after Plain Chest Radiography for Mass Screening for Lung Cancer
91. Locally Advanced Non-Small-Cell Lung Cancer: The Role of Neoadjuvant or Definitive Chemoradiation
92. Revisions in the International System for Staging Lung Cancer
93. Development of Molecular Approaches to Early Lung Cancer Detection
94. Chemotherapy in Non-Small-Cell Lung Cancer: A Meta-Analysis using Updated Data on Individual Patients from 52 Randomises Clinical Trials
95. Induction Therapy for Non-Small-Cell Lung Cancer with Involved Mediastinal Nodes in Multiple Stations
96. Adjuvant Treatment of Stage I Lung Cancer With High-Dose Vitamin A
97. Frequency and Prognostic Significance of Isolated Tumour Cells in Bone Marrow of Patients with Non-Small Lung Cancer Without Overt Metastases
98. Photodynamic Laser Therapy for the Treatment of Early-Stage Bronchogenic Carcinoma
99. Detection and Quantification of Circulating Cancer Cells in the Peripheral Blood of Lung Cancer Patients
100. Induction Treatment for Resectable Non-Small Lung Cancer. A Consensus Report
101. Induction Chemotherapy before Surgery for Early-Stage Lung Cancer: A Novel Approach. Bimodality Lung Oncology Team
102. Neoadjuvant Etoposide, Ifosfamide, and Cisplatin Followed by Concomitant Thoracic Radiotherapy and Continous Cisplatin Infusion in Stage IIIB Non-Small-Cell Lung Cancer
103. Role of Bronchoscopy in Lung Cancer
104. Evidence-Based Outcomes for Patients with Advanced Non-Small Cell Lung Cancer
105. Evidence-Based Medicine in the Treatment of Non-Small-Cell Lung Cancer
106. A randomized trial comparing preoperative chemotherapy plus surgery alone in patients with non-small-cell lung cancer
107. Preresectional Chemotherapy in Stage IIIA Non-Small-Cell Lung Cancer: A 7-Year Assessment of a Randomized Controlled Trial
108. Genetic Manipulations for Treatment of Lung Cancer
109. Long-Term Follow-Up of Patients Enrolled in a Randomized Trial Comparing Perioperative Chemotherapy and Surgery with Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer
110. A randomized trial comparing perioperative chemotherapy and surgery alone in resectable stage IIIA non-small-cell lung cancer
111. Gene Replacement Strategies for Lung Cancer
112. Surgical Treatment of Patients with N2 Disease
113. Evidence-Based Outcomes for Patients with Non-Small-Cell Lung Cancer Undergoing Resection
114. Multitargeted Antifolate LY231514 as First-Line Chemotherapy for Patients with Advanced Non-Small-Cell Lung Cancer: A Phase II Study
115. Treatment of NSCLC: Radiotherapy
116. New Drugs for New Chemotherapy Standards
117. Chemotherapy for Advanced Non-Small-Cell Lung Cancer
118. Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results of a Multicenter Phase II Study
119. Development of Inhalational Agents for Oncologic Use
120. Treatment of NSCLC: Chemotherapy
121. Prospective Randomized Trial of Docetaxel versus Best Supportive Care in Patients with Non-Small-Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy
122. Biology and Chemoprevention of Lung Cancer
123. Detectable Tumor Cells in the Blood and Bone Marrow: Smoke or Fire?
124. Duration of Chemotherapy in Advanced Non-Small-Cell Lung Cancer: A Randomized Trial of Three Versus Six Courses of Mitomycin, Vinblastine, and Cisplatin
125. Chemotherapy for Stage IV Non-Small-Cell Lung Cancer
126. Adjuvant Therapy of Rescted Non-Small Cell Lung Cancer
127. Multimodality Therapy in Locally Advanced Non-Small-Cell Lung Cancer (NSCLC Stage IIIB)
128. A Terapêutica no Carcinoma Brônquico de não Pequenas Células
129. Argumentos a Favor da Prescrição da Quimioterapia (Qt) no Carcinoma Pulmonar de Não Pequenas Células (CPNPC)
130. Terapêutica Génica do Cancro do Pulmão
131. Quimioterapia do CPNPC: Dados Actuais para uma Síntese do Tema
132. Poluição e Cancro do Pulmão
133. Progressos Terapêuticos no Cancro do Pulmão. Perspectiva Actual e Futura
134. Cancro do Pulmão: Revisão de 230 Casos. Livro de Resumos (Comunicações Orais)
135. Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
136. Endobronchial Brachytherapy
137. Controvérsias no Cancro do Pulmão (II). Terapêutica
138. Combination Chemotherapy with Cisplatin, Ifosfamid and Etoposide (PIE) and Whole Brain Radiotherapy (WBR) for Patients with Non-Small Cell Lung Cancer (NSCLC) with Brain Metastases
139. Docetaxel in Patients with Non-Small-Cell Lung Cancer Relapsed or Progressed after First-Line Chemotherapy
140. Sensitive and Specific Monoclonal Antibody Recognition of Human Lung Cancer Antigen on Preserved Sputum Cells: A New Approach to Early Lung Cancer Detection
141. neu
142. Endobronchial Laser Therapy
143. Randomized Trial of Chemoprevention with Vitamin A and N-Acetylcysteine in Patients with Cancer of the Upper and Lower Airways: The Euroscan Study
144. Broncoscopia de Intervenção no Cancro do Pulmão
145. A Randomized Phase II Study of Gemcitabine or Paclitaxel or Vinorelbine with Cisplatin as Induction Chemotherapy (Ind CT) and Concomitant Chemoradiotherapy (XRT) for Unresectable Stage III Non-Small-Cell Lung Study 9431)
146. Postoperative Adjuvant Therapy for Patients With Resected Non-Small-Cell Lung Cancer: Still Controversial After all These Years
147. Unfavorable Prognosis of Patients with Stage II Non-Small-Cell Lung Cancer Associated with Macroscopic Nodal Metastases